Assenagon Asset Management »

Cerevel Therapeutics Hldng I shares owned by Assenagon Asset Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Assenagon Asset Management from 13F filings

Historical chart of Assenagon Asset Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Assenagon Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 300k 42.40

More positions owned by Assenagon Asset Management

Amazon (AMZN)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Meta Platforms Cl A (META)
Jpmorgan Chase & Co Put Put Option
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Apple Put Put Option
Pdd Holdings Sponsored Ads (PDD)
Intuitive Surgical Com New (ISRG)
Bank America Corp Put Put Option
Citigroup Put Put Option

View all positions for Assenagon Asset Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I